Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8537306 | Progress in Neuro-Psychopharmacology and Biological Psychiatry | 2018 | 6 Pages |
Abstract
Our results indicate elevated levels of VEGF in MES patients that are unaltered in FEP individuals. Longitudinal studies are required to disentangle whether elevated levels of VEGF in MES patients reflect illness progression, comorbid physical health impairments or appear due to medication effects.
Related Topics
Life Sciences
Neuroscience
Biological Psychiatry
Authors
BÅażej Misiak, Filip Stramecki, BartÅomiej StaÅczykiewicz, Dorota Frydecka, Alba Lubeiro,